SI
Sofinnova Investments Portfolio holdings
AUM
$1.63B
1-Year Est. Return
33.42%
1 Year Est. Return
+33.42%
AUM
$1.47B
AUM Growth
+$144M
(+11%)
Holding
73
Top Buys
| 1 | +$70M | |
| 2 | +$49.3M | |
| 3 | +$46.3M | |
| 4 |
Eli Lilly
LLY
|
+$34.5M |
| 5 |
United Therapeutics
UTHR
|
+$34.1M |
Top Sells
| 1 | +$111M | |
| 2 | +$50.6M | |
| 3 | +$47.6M | |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$23.1M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$22.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INZY
26
DELISTED
Inozyme Pharma
INZY
| $17.1M | 1.05% |
4,280,308
|
|
||
27
Cogent Biosciences
COGT
$5.15B
| $16.9M | 1.03% |
2,355,505
+173,384
|
|
||
28
Replimune Group
REPL
$705M
| $16.8M | 1.03% |
1,806,529
-673,410
|
|
||
29
Avidity Biosciences
RNA
$10.7B
| $16.6M | 1.02% |
584,801
+204,870
|
|
||
30
Syndax Pharmaceuticals
SNDX
$1.44B
| $14.3M | 0.87% |
1,524,440
-750,783
|
|
||
31
Cidara Therapeutics
CDTX
$6.84B
| $12.2M | 0.75% |
+251,031
|
|
||
32
Immatics
IMTX
$1.24B
| $12.1M | 0.74% |
2,240,528
+686,224
|
|
||
33
Exact Sciences
EXAS
$12.7B
| $11.1M | 0.68% |
+208,300
|
|
||
34
Pharvaris
PHVS
$1.53B
| $10.3M | 0.63% |
585,532
-7,871
|
|
||
35
Inhibrx
INBX
$1.15B
| $10.1M | 0.62% |
708,678
+10,762
|
|
||
36
Arcus Biosciences
RCUS
$2.48B
| $9.9M | 0.61% |
1,216,016
+178,240
|
|
||
|
YMAB
37
DELISTED
Y-mAbs Therapeutics
YMAB
| $9.9M | 0.61% |
2,194,278
|
|
||
38
Axsome Therapeutics
AXSM
$7.04B
| $9.77M | 0.6% |
93,610
-81,707
|
|
||
|
BIOA
39
BioAge Labs
BIOA
$280M
| $9.52M | 0.58% |
2,304,901
|
|
||
40
Edgewise Therapeutics
EWTX
$2.41B
| $9.4M | 0.57% |
716,873
+374,655
|
|
||
41
Immunome
IMNM
$1.57B
| $7.24M | 0.44% |
778,476
-10,190
|
|
||
42
Dyne Therapeutics
DYN
$2.68B
| $5.85M | 0.36% |
614,865
-102,031
|
|
||
43
Savara
SVRA
$875M
| $5.6M | 0.34% |
2,457,352
-3,024,314
|
|
||
44
Apogee Therapeutics
APGE
$4.47B
| $3.31M | 0.2% |
+76,180
|
|
||
45
NextCure
NXTC
$26.5M
| $1.23M | 0.08% |
222,655
|
|
||
46
Establishment Labs
ESTA
$1.86B
| $1.2M | 0.07% |
28,120
-555
|
|
||
|
JBIO
47
Jade Biosciences
JBIO
$492M
| $1.07M | 0.07% |
107,391
|
|
||
|
MTSR
48
DELISTED
Metsera Inc
MTSR
| $1.03M | 0.06% |
36,191
-609
|
|
||
49
Scholar Rock
SRRK
$3.6B
| $937K | 0.06% |
26,440
-89,677
|
|
||
50
Bolt Biotherapeutics
BOLT
$8.77M
| $795K | 0.05% |
137,721
-1
|
|